Biophysical and biological evaluation of free and liposomal doxorubicin and β-carotene reveals enhanced therapeutic selectivity in MCF-7 breast cancer cells
≈ 20 µg/mL). Overall, these findings suggest that liposomal co-delivery of β-carotene and doxorubicin may enhance therapeutic efficacy while potentially reducing off-target toxicity.
Authors
- M G.Ibrahim
- Hany Elrahman
- Ayman M. Ibrahim (ORCID: https://orcid.org/0000-0003-1865-5112)
- Mahmoud A. Elbaset
- Medhat W. Shafaa
- Michael Masoomi
Institutions
- Benha University (EG)
- Portsmouth Regional Hospital (US)
- University of Portsmouth (GB)
- Helwan University (EG)
Publication Details
- Journal
- Journal of Liposome Research
- Published
- 2026-05-12
- DOI
- https://doi.org/10.1080/08982104.2026.2671264
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00